• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Cardiovascular risk associated with social determinants of health at individual and area levels

byJayden BerdugoandAlex Chan
May 5, 2024
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cohort study, individual and area level social determinants of health (SDOH) were associated with an increased risk in atherosclerotic cardiovascular disease (ASCVD) events. 

Evidence Rating Level: 1 (Excellent) 

Social determinants of health (SDOH) are several conditions that affect people’s health, functioning, and quality of life. Cardiovascular health is often affected by an individual’s SDOH along with the area’s SDOH. Atherosclerotic cardiovascular disease (ASCVD) has previously been studied and found to have an association with both individual and area level socioeconomic status. However, the quantitative risk associated with poor SDOH is poorly characterized. In this cohort study, participants were excluded if they had a history of ASCVD at baseline (6841 individuals), missing SDOH (8453 individuals), missing covariates included in the pooled cohort equations (PCEs) (1472 individuals), or missing ASCVD follow-up incidents (297 individuals). Many of the patient characteristics such as employment status (unemployed, not employed including those who were retired), race and ethnicity (Chinese American, Hispanic, non-Hispanic Black, non-Hispanic White), education level (less than high school, high school, or higher education), and income (less than $35 000, $35 000 or higher), were self-reported by the participants. To understand the effects of SDOH on ASCVD, the time to first ASCVD event was measured as the main outcome. Cox proportional hazard models were used to understand the association between every SDOH and incident ASCVD event. Included in the final study were 26 316 participants (mean [SD] age at baseline, 61.0 [9.1] years). Of the participants, there was at least 1 adverse individual-level SDOH in 11 764 participants (44.7%) and at least 1 in adverse area-level SDOH in 10 908 (41.5%) participants. At the individual level and the area level, SDOH was associated with a greater risk of ASCVD for education (individual: hazard ratio [HR], 1.39 [95% CI, 1.25-1.55]; area: HR, 1.31 [95% CI, 1.20-1.42]) low income (individual: 1.35 [95% CI, 1.25-1.47]; area: HR, 1.28 [95% CI, 1.17-1.40]) and unemployment (individual: HR, 1.61 [95% CI, 1.24-2.10]; area: HR, 1.25 [95% CI, 1.14-137]). Overall, both individual and area level SDOH were associated with a higher risk of ASCVD events. Additionally, adding individual and area SDOH to the PCEs improved discrimination slightly while also improving calibration for estimating ASCVD risk in Black people.

Click to read the study in JAMA Network Open

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

Tags: cardiologychronic diseasepublic healthsessocial determinants of health
Previous Post

Access to mental health and substance use treatment improved with comprehensive primary care plus program

Next Post

2 Minute Medicine May 6th, 2024

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

April 2, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

February 17, 2026
Next Post
Provision of medically-tailored meals linked with lower admissions and medical spending

2 Minute Medicine May 6th, 2024

#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

PET scans in early-stage Hodgkin’s lymphoma may help guide therapy [RAPID trial]

Higher national health expenditure correlates with better lymphoid malignancy survival rates in European countries.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A multidisciplinary home-based intervention may reduce risk of falls after stroke
  • Prednisone may have bone and cardiovascular benefits compared to hydrocortisone therapy in adrenal insufficiency
  • Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.